Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Nectar Lifesciences Ltd - 532649 - Intimation Of Approval Of Application Under Regulation 31A Of LODR Regulations.

 We hereby inform you that the Company has received the approval, from BSE Limited ('BSE') vide it's email dated June 01, 2021 and National Stock Exchange of India Limited ('NSE') vide it's email and letter dated June 01, 2021, of application under Regulation 31A of LODR Regulations. Approval email received from BSE and approval letter received from NSE, are enclosed herewith for your reference.
01-06-2021
Bigul

Nectar Lifesciences Ltd - 532649 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.

 The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June 01, 2021 for Sanjiv Goyal & Sanjiv (HUF)
01-06-2021
Bigul

Nectar Lifesciences Ltd - 532649 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

 The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 01, 2021 for Sanjiv Goyal & Sanjiv (HUF)
01-06-2021
Bigul

NECTAR LIFESCIENCES LTD. - 532649 - Clarification

 With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Nectar Lifesciences Ltd has submitted to BSE a copy of Clarification is enclosed.
26-04-2021
Bigul

Nectar Lifesciences Ltd - 532649 - Clarification

 With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Nectar Lifesciences Ltd has submitted to BSE a copy of Clarification is enclosed.
26-04-2021
Bigul

Nectar Lifesciences Ltd - 532649 - Clarification sought from Nectar Lifesciences Ltd

 The Exchange has sought clarification from Nectar Lifesciences Ltd on April 26, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
26-04-2021
Bigul

NECTAR LIFESCIENCES LTD. - 532649 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to the Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 08, 2019, please find attached herewith the Annual Secretarial Compliance Report for the year ended on March 31, 2021 duly signed by Company Secretary in practice.
15-04-2021
Bigul

Nectar Lifesciences Ltd - 532649 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayNECTAR LIFESCIENCES LTD. 2CINL24232PB1995PLC016664 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 150.00 4Highest Credit Rating during the previous FY A- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)BRICKWORK RATINGS INDIA PRIVATE LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkNSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Sukriti Saini Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Sandeep Goel Designation: Chief Financial Officer EmailId: [email protected] Date: 12/04/2021 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
12-04-2021
Bigul

NECTAR LIFESCIENCES LTD. - 532649 - Shareholding for the Period Ended March 31, 2021

 Nectar Lifesciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here
07-04-2021
Bigul

NECTAR LIFESCIENCES LTD. - 532649 - Compliance Under Regulation 40(10) Of The Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Pursuant to captioned regulation, please find enclosed herewith a copy of the certificate, received from a Company Secretary in Practice as required under Regulation 40(9) of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the half year ended March 31, 2021.
05-04-2021
Next Page
Close

Let's Open Free Demat Account